Characteristic | Pre-Pandemic Cohort (n = 36,362) | COVID-19 Cohort (n = 17,545) | Standardized Difference |
---|---|---|---|
PCP sex, n(%) | |||
Female | 13,064 (35.9%) | 6,737 (38.4%) | 0.051 |
Male | 23,101 (63.5%) | 10,682 (60.9%) | 0.054 |
Missing | 197 (0.5%) | 126 (0.7%) | 0.022 |
PCP age at index date | |||
Mean (SD) | 54.93 (11.39) | 55.52 (11.01) | 0.053 |
Median (IQR) | 55 (47–63) | 56 (48–63) | 0.046 |
PCP years since date of first certification at index date | |||
Mean (SD) | 24.31 (8.50) | 25.37 (8.31) | 0.13 |
Median (IQR) | 23 (17–31) | 24 (18–31) | 0.13 |
PCP country of medical school, n(%) | |||
Canadian | 22,793 (62.7%) | 10,075 (57.4%) | 0.11 |
Non-Canadian | 10,139 (27.9%) | 4,758 (27.1%) | 0.01 |
Missing | 3,430 (9.4%) | 2,712 (15.5%) | 0.18 |
PCP patient enrollment model (PEM) type, n(%) | |||
FHG/CCM | 10,853 (29.8%) | 4,995 (28.5%) | 0.03 |
FHT | 11,090 (30.5%) | 5,476 (31.2%) | 0.016 |
Non-FHT | 12,158 (33.4%) | 6,061 (34.5%) | 0.022 |
TFFS | 1,666 (4.6%) | 766 (4.4%) | 0.01 |
Other PEM | 409 (1.1%) | 170 (1.0%) | 0.015 |
Not enough visits to attribute to usual PCP | 181–185 | 77 (0.4%) | 0.01 |
Missing | 1–5 | 0 (0.0%) | 0.01 |